Chymase inhibition attenuates monocrotaline-induced sinusoidal obstruction syndrome in hamsters.

Abstract:

:Chymase stored in mast cells activates matrix metalloproteinase (MMP)-9, which may relate to the progression of sinusoidal obstruction syndrome (SOS). We investigated the preventive effect of a chymase inhibitor, TY-51469, on monocrotaline-induced SOS in hamsters. Hamsters were orally administrated with a single dose of monocrotaline (120 mg/kg) to induce SOS. Treatment with TY-51469 (1 mg/kg per day) or placebo had started 3 days before the monocrotaline administration. Two days after the monocrotaline administration, significant increases in aspartate aminotransferase, alanine aminotransferase and total bilirubin and a significant reduction of albumin were observed in plasma, but their changes were significantly attenuated by treatment with TY-51469. The numerous hepatic necrosis areas were observed in the placebo-treated group, but the ratio of necrotic area to total area in liver had been significantly reduced by treatment with TY-51469. Both chymase activity and MMP-9 level in liver were significantly augmented in the placebo-treated group. Furthermore, tumor necrosis factor (TNF)-α level in liver was also augmented in the placebo-treated group. However, the chymase activity and levels of MMP-9 and TNF-α were significantly attenuated in the TY-51469-treated group. Until 14 days after monocrotaline administration, survival rates in the placebo- and TY-51469-treated groups were 25% and 70%, respectively, and a significant difference was observed. In conclusion, chymase inhibition by TY-51469 may prevent the accelerating of severity in monocrotaline-induced SOS in hamsters.

journal_name

Curr Med Chem

authors

Masubuchi S,Komeda K,Takai S,Jin D,Tashiro K,Li ZL,Otsuki Y,Okamura H,Hayashi M,Uchiyama K

doi

10.2174/0929867311320210008

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

2723-9

issue

21

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-20130315-20

journal_volume

20

pub_type

杂志文章,评审
  • NK-1 receptor antagonists: a new paradigm in pharmacological therapy.

    abstract::The neuropeptide substance P (SP) shows a widespread distribution in both the central and peripheral nervous systems and it is known that after binding to the neurokinin-1 (NK-1) receptors, SP regulates many biological functions in the central nervous system such as emotional behaviour, stress, depression, anxiety, em...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711795496746

    authors: Muñoz M,Coveñas R

    更新日期:2011-01-01 00:00:00

  • Recent Advances and Challenges in Steroid Metabolomics for Biomarker Discovery.

    abstract:BACKGROUND:Steroid hormones belong to a group of low-molecular weight compounds which are responsible for maintenance of various body functions, thus, their accurate assessment is crucial for evaluation of biosynthetic defects. The development of reliable methods allowing disease diagnosis is essential to improve early...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666171113120810

    authors: Kotłowska A,Szefer P

    更新日期:2019-01-01 00:00:00

  • The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications.

    abstract::Genito-urinary malignancies (prostate, bladder, renal and testicular cancers) rank high among human tumors with an incidence that varies with age and organ involvement. Prostate cancer is the most commonly detected male cancer followed by bladder and kidney cancers, less frequent in women. Testicular cancer, although ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711797535182

    authors: Cantile M,Franco R,Schiavo G,Procino A,Cindolo L,Botti G,Cillo C

    更新日期:2011-01-01 00:00:00

  • Calcium metabolism & hypercalcemia in adults.

    abstract::Calcium is essential for many metabolic process, including nerve function, muscle contraction, and blood clotting. The metabolic pathways that contribute to maintain serum calcium levels are bone remodeling processes, intestinal absorption and secretion, and renal handling, but hypercalcemia occurs when at least 2 of ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986711796642599

    authors: Lumachi F,Motta R,Cecchin D,Ave S,Camozzi V,Basso SM,Luisetto G

    更新日期:2011-01-01 00:00:00

  • Healthy Diet and Reduction of Chronic Disease Risks of Night Shift Workers.

    abstract:BACKGROUND:The large increase in epidemiological studies on night shift work is due to the important effects of night shift work on workers' health and psychophysical wellbeing. The short-term effects-insomnia, difficulties in managing work and private life, lower work performance, and more work and extra-work accident...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170720160632

    authors: Ferri GM,Cavone D,Intranuovo G,Macinagrossa L

    更新日期:2019-01-01 00:00:00

  • Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects.

    abstract:BACKGROUND:Chronic Liver Disorders (CLD), caused by the lifestyle patterns like alcoholism or by non-alcoholic fatty liver disease or because of virus-mediated hepatitis, affect a large population fraction across the world. CLD progresses into end-stage diseases with a high mortality rate. Liver transplant is the only ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666191004161802

    authors: Mahmood A,Seetharaman R,Kshatriya P,Patel D,Srivastava AS

    更新日期:2020-01-01 00:00:00

  • A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase.

    abstract::A growing body of evidence has shown that oxidative stress may be involved in the development of vascular complications associated with diabetes. However, the molecular mechanism for increased reactive oxygen species (ROS) production in diabetes remains uncertain. Among various possible mechanisms, attention have incr...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457133

    authors: Inoguchi T,Tsubouchi H,Etoh T,Kakimoto M,Sonta T,Utsumi H,Sumimoto H,Yu HY,Sonoda N,Inuo M,Sato N,Sekiguchi N,Kobayashi K,Nawata H

    更新日期:2003-09-01 00:00:00

  • Phenolic compounds from plants as nitric oxide production inhibitors.

    abstract::Nitric oxide (NO) is a diatomic free radical produced from L-arginine by constitutive and inducible nitric oxide synthase (cNOS and iNOS) in numerous mammalian cells and tissues. Nitric oxide (NO), superoxide (O2-) and their reaction product peroxynitrite (ONOO-) may be generated in excess during the host response aga...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711795029690

    authors: Conforti F,Menichini F

    更新日期:2011-01-01 00:00:00

  • Diagnosis and therapeutic approaches to transthyretin amyloidosis.

    abstract::Hereditary amyloidogenic transthyretin (TTR) (ATTR) amyloidosis is an autosomal dominant form of fatal hereditary amyloidosis. Owing to progress in biochemical and molecular genetic analyses, this disease is now believed to occur worldwide. As of today, reports of about 120 different points of single or double mutatio...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712800269317

    authors: Ando Y,Ueda M

    更新日期:2012-01-01 00:00:00

  • Perspectives on cancer therapy: cell cycle blockers and perturbators.

    abstract::Over the past few decades, remarkable advances have been achieved in cancer therapy, including chemotherapeutic agents, their mode of application and more broader therapeutic strategies. Promising new therapeutic targets have emerged in the past ten years as a result of recent advances in our understanding of the path...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033456495

    authors: Dobashi Y,Takehana T,Ooi A

    更新日期:2003-12-01 00:00:00

  • Ligand-protein docking: cancer research at the interface between biology and chemistry.

    abstract::In recent years there has been a growing interest in computer-based screening. One of the driving forces has been the increased efficiency of protein crystallography leading to the real possibility of using structure-based design as a significant contributor to the discovery of novel ligands. In 1957 after 22 years of...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457809

    authors: Glen RC,Allen SC

    更新日期:2003-05-01 00:00:00

  • New trends in the design of drugs against Alzheimer's disease.

    abstract::First described by Alois Alzheimer in 1907, Alzheimer's disease (AD) is the most common dementia type, affecting approximately 20 million people worldwide. As the population is getting older, AD is a growing health problem. AD is currently treated by symptomatic drugs, the acetylcholinesterase inhibitors, based on the...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043364946

    authors: Francotte P,Graindorge E,Boverie S,de Tullio P,Pirotte B

    更新日期:2004-07-01 00:00:00

  • Drug excipients.

    abstract::The therapeutical use of drugs involves the application of dosage forms, serving as carrier systems together with several excipients to deliver the active ingredient to the site of action. Drug delivery technology combines an understanding of medicinal chemistry and pharmacology with the skill of formulation, aiming t...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706778201648

    authors: Kalász H,Antal I

    更新日期:2006-01-01 00:00:00

  • The role of estrogen and estrogen receptors in chemoresistance.

    abstract::Drug resistance is one of the major obstacles limiting the success of cancer chemotherapy. Biological mechanisms contributing to drug resistance may be present de novo and related to inherent features or may be raised after exposure to anticancer drugs. In recent years, both clinical observations and experimental stud...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711797379348

    authors: Sui M,Zhang H,Fan W

    更新日期:2011-01-01 00:00:00

  • New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.

    abstract::Patients with homozygous familial hypercholesterolemia (HoFH) represent the most severe patients within the spectrum of dyslipidemias. Untreated Low-Density Lipoprotein Cholesterol (LDL-C) levels in these patients are usually in the range 500 to 1200 mg/dL. Moreover, these patients exhibit a scarce responsiveness or e...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712803341485

    authors: Stefanutti C,Morozzi C,Di Giacomo S

    更新日期:2012-01-01 00:00:00

  • Nutritional iron deficiency: the role of oral iron supplementation.

    abstract::Nutritional iron deficiency represents a relevant health problem mainly in developing countries. Children and pregnant women represent the main target of this disease, and the low amount of bio-available iron mostly depends on plant-based diets. Iron deficiency may have serious consequences, with severe impairment of ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666140706143925

    authors: Lachowicz JI,Nurchi VM,Fanni D,Gerosa C,Peana M,Zoroddu MA

    更新日期:2014-01-01 00:00:00

  • Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy.

    abstract::The kidney has numerous complex interactions with the heart, including shared risk factors (e.g., hypertension, dyslipidemia, etc.) and mutual amplification of morbidity and mortality. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various alterations in cardiovascular system, metabolic homeos...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160309114246

    authors: Potpara TS,Jokic V,Dagres N,Marin F,Prostran MS,Blomstrom-Lundqvist C,Lip GY

    更新日期:2016-01-01 00:00:00

  • State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

    abstract::The bi-aryl urea multi-kinase inhibitor Sorafenib (BAY 43-9006, Nexavar) was initially approved for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Eleven years after its first description in PubMed, the therapeutic potential of Sorafenib has been evaluated in an increasing nu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712803341548

    authors: Zauli G,Voltan R,Tisato V,Secchiero P

    更新日期:2012-01-01 00:00:00

  • Non peptidic alphavbeta3 antagonists: recent developments.

    abstract::The alphavbeta3 receptor, which are members of the group of the cellular adhesion molecules (CAM), are heterodimeric transmembrane glycoprotein receptors involved in processes such as cell-cell and cell-matrix adhesion, cell migration and signaling. Integrin alphavbeta3 receptor is expressed on almost all cells origin...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867053363522

    authors: Cacciari B,Spalluto G

    更新日期:2005-01-01 00:00:00

  • Renin-angiotensin system block and atrial fibrillation.

    abstract::Atrial fibrillation is the most common disorder of cardiac rhythm. In spite of diagnosis simplicity, patients with atrial fibrillation are difficult to treat. In the recent years with the description of the phenomenon called remodelling, it has been possible to better define the principle mechanisms responsible for in...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867054020954

    authors: Lombardi F,Terranova P

    更新日期:2005-01-01 00:00:00

  • Mechanistic Insights of Chemicals and Drugs as Risk Factors for Systemic Lupus Erythematosus.

    abstract::Systemic Lupus Erythematosus (SLE) is a chronic and relapsing heterogenous autoimmune disease that primarily affects women of reproductive age. Genetic and environmental risk factors are involved in the pathogenesis of SLE, and susceptibility genes have recently been identified. However, as gene therapy is far from cl...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190404140658

    authors: Pan Q,Guo Y,Guo L,Liao S,Zhao C,Wang S,Liu HF

    更新日期:2020-01-01 00:00:00

  • Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain.

    abstract::The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical brain is accepted as the main pathological hallmark of Alzheimer's disease (AD). According to the amyloid cascade hypothesis, the Aβ deposition in the brain appears to be a good diagnostic biomarker for AD and may also be a good predictive biomar...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/09298673113209990216

    authors: Cui M

    更新日期:2014-01-01 00:00:00

  • Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics.

    abstract::G protein-coupled receptor (GPCR) (also known as seven-transmembrane domain receptor) superfamily represents the largest protein family in the human genome. These receptors respond to various physiological ligands such as photons, odors, pheromones, hormones, ions, and small molecules including amines, amino acids to ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/09298673113209990168

    authors: Yonezawa T,Kurata R,Yoshida K,Murayama MA,Cui X,Hasegawa A

    更新日期:2013-01-01 00:00:00

  • Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors.

    abstract::Inflammation is an initial response of the body to a harmful stimuli and it is achieved by the increased movement of leukocytes (especially granulocytes) from blood into injured tissues. It is required for healing wounds and infections. Despite their indispensable role in microbial killing, the inflammation reactions ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160607111806

    authors: Soubhye J,Aldib I,Delporte C,Prévost M,Dufrasne F,Antwerpen PV

    更新日期:2016-01-01 00:00:00

  • Pharmacological implications of MMP-9 inhibition by ACE inhibitors.

    abstract::Matrix metalloproteinase-9 (MMP-9) plays an important role in the onset and prognosis of myocardial infarction. Targets of angiotensin converting enzyme (ACE) inhibitors might include not only ACE but also MMP-9, and ACE seems to be closely associated with complications of hypertension such as cardiovascular remodelin...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986709787846514

    authors: Yamamoto D,Takai S

    更新日期:2009-01-01 00:00:00

  • Mast cells as critical effectors of host immune defense against Gram-negative bacteria.

    abstract::Mast cells are best known as central effector cells in IgE-mediated type I allergic diseases including asthma and hay fever. An increasing amount of evidence, however, has demonstrated that mast cells are sentinel cells playing a critical role in host defense against invading microbes. Mast cells are located immediate...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712799828319

    authors: Matsuguchi T

    更新日期:2012-01-01 00:00:00

  • Nanoparticles: functionalization and multifunctional applications in biomedical sciences.

    abstract::Rapid innovations in nanomedicine have increased the likelihood that engineered nanomaterials will eventually come in contact with humans and the environment. The advent of nanotechnology has created strong interest in many fields such as biomedical sciences and engineering field. Central to any significant advances i...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710794183024

    authors: Subbiah R,Veerapandian M,Yun KS

    更新日期:2010-01-01 00:00:00

  • New Tracers and New Perspectives for Molecular Imaging in Lewy Body Diseases.

    abstract::The term Lewy body diseases (LBDs) refers to a subset of neurodegenerative disorders that share the accumulation of the so-called Lewy bodies (LB) including: Parkinson's disease (PD), dementia with Lewy bodies (DLB), and PD later characterized by the occurrence of dementia (PDD). Moreover, multiple system atrophy (MSA...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170609080000

    authors: Bauckneht M,Arnaldi D,Nobili F,Aarsland D,Morbelli S

    更新日期:2018-01-01 00:00:00

  • Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products.

    abstract:BACKGROUND:Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, is the leading cause of cryptogenic cirrhosis and has consistently been implicated in related metabolic disorders, such as dyslipidemia and type 2 diabetes (T2D). However, the pathogenesis of NAFLD remains to be elucidated, and ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170404142450

    authors: Xu G,Huang K,Zhou J

    更新日期:2018-01-01 00:00:00

  • Terpenes, Phenylpropanoids, Sulfur and Other Essential Oil Constituents as Inhibitors of Cholinesterases.

    abstract::Essential oils constituents are a diverse family of low molecular weight organic compounds with comprehensive biological activity. According to their chemical structure, these active compounds can be divided into four major groups: terpenes, terpenoids, phenylpropenes, and "others". In addition, they may contain diver...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180330092607

    authors: Burčul F,Blažević I,Radan M,Politeo O

    更新日期:2020-01-01 00:00:00